| P50 | author | Bradford C. Berk | Q37828966 |
| P2093 | author name string | Jun-ichi Abe | |
| P2860 | cites work | A role for mitochondria in NLRP3 inflammasome activation | Q28131794 |
| | Central roles of NLRs and inflammasomes in viral infection | Q28395291 |
| | Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 |
| | Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes | Q29615593 |
| | NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 |
| | Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques | Q30054591 |
| | Shear stress, SIRT1, and vascular homeostasis | Q33933093 |
| | Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome | Q35006409 |
| | Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2 | Q35906034 |
| | Expanding roles for SREBP in metabolism | Q36303731 |
| | Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction. | Q36749832 |
| | Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. | Q37233061 |
| | The inflammasome: an integrated view | Q37925072 |
| | Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms | Q37935006 |
| | A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? | Q37995073 |
| | SREBP: a novel therapeutic target | Q38069003 |
| | A pathway approach to investigate the function and regulation of SREBPs | Q38091672 |
| | Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. | Q42729920 |
| | Shear stress activation of SREBP1 in endothelial cells is mediated by integrins | Q43852804 |
| | Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) | Q85063666 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| | inflammasome complex | Q412405 |
| P304 | page(s) | 579-582 | |
| P577 | publication date | 2013-07-09 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Atheroprone flow activation of the sterol regulatory element binding protein 2 and nod-like receptor protein 3 inflammasome mediates focal atherosclerosis | |
| P478 | volume | 128 | |